HLA-DO: A useful marker to distinguish florid follicular hyperplasia from follicular lymphoma by flow cytometry

American Journal of Clinical Pathology

Volumn 119, Issue 6, 2003, Pages 842-851

  Chen, Xinjian ^b   Jensen, Peter E ^b   Li, Shiyong ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Florid follicular hyperplasia; Flow cytometry; Follicular lymphoma; Germinal center B cells; HLA DO

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DO ANTIGEN; IMMUNOGLOBULIN LIGHT CHAIN; HLA D ANTIGEN; HLA DO ANTIGENS; HLA-DO ANTIGENS; MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DOWN REGULATION; FLOW CYTOMETRY; FOLLICULAR HYPERPLASIA; FOLLICULAR LYMPHOMA; GERMINAL CENTER; HUMAN; HUMAN CELL; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PRIORITY JOURNAL; TUMOR CELL; CHEMISTRY; IMMUNOLOGY; LYMPH NODE; PATHOLOGY;

B-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HLA-D ANTIGENS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, FOLLICULAR; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0037871810     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/WP6H-6UD4-DXMR-Q86T     Document Type: Article

References (23)

1. Jaffe EJ, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: 1ARC Press; 2001. World Health Organization Classification of Tumours.
2. Kuppers RS, Klein U, Hansmann ML, et al. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
3. Husson H, Carideo EG, Neuberg D, et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood. 2002;99:282-289.
4. Belessi C, Stamatopoulos K, Stavroyianni N, et al. Somatic hypermutation targeting to intrinsic hotspots of immunoglobulin genes in follicular lymphoma and multiple myeloma. Leukemia. 2001;15:1772-1778.
5. Utz GL, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Hum Pathol. 1993;24:1155-1158.
6. Cong P, Raffeld M, Teruya-Feldstein J, et al. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;99:3376-3382.
7. Li S, Eshleman JR, Borowitz MJ. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma. Am J Clin Pathol. 2002;118:229-234.
8. Karlsson L, Surh CD, Sprent J, et al. A novel class II MHC molecule with unusual tissue distribution. Nature. 1991;351:485-488.
9. Karlsson L, Peterson PA. The alpha chain gene of H-2O has an unexpected location in the major histocompatibility complex. J Exp Med. 1992;176:477-483.
10. Jensen PE, Weber DA, Thayer WP, et al. Peptide exchange in MHC molecules. Immunol Rev. 1999;172:229-238.
11. Sherman MA, Weber DA, Jensen PE. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 1995;3:197-205.
12. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 1995;82:155-165.
13. Sloan VS, Cameron P, Porter G, et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 1995;375:802-806.
14. Chen X, Laur O, Kambayashi T, et al. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med. 2002;195;1053-1062.
15. Glazier KS, Hake SB, Tobin HM, et al. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J Exp Med. 2002;195:1063-1069.
16. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
17. Robetorye RS, Bohling SD, Morgan JW, et al. Microarray analysis of B-cell lymphoma cell lines with the t(14;18). J Mol Diagn. 2002;4:123-136.
18. Vaandrager JW, Schuuring E, Raap T, et al. Interphase FISH detection of bcl2 rearrangement in follicular lymphoma using breakpoint-flanking probes. Genes Chromosomes Cancer. 2000;27:85-94.
19. Skinnider BF, Horsman DE, Dupuis B, et al. bcl-6 and bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3p27 and 18q21 chromosomal abnormalities. Hum Pathol. 1999;30:803-808.
20. Liu Y, Hernandez AM, Shibata D, et al. bcl2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A. 1994;91:8910-8914.
21. Almasri NM, Iturraspe JA, Braylan RC. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles. Arch Pathol Lab Med. 1998;122:539-544.
22. Bellido M, Rubiol E, Ubeda J, et al. Flow cytometry using the monoclonal antibody CD10-Pe/Cy5 is a useful tool to identify follicular lymphoma cells. Eur J Haematol. 2001;66:100-106.
23. Cornfield DB, Mitchell DM, Almasri NA, et al. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20. Am J Clin Pathol. 2000;114:258-263.